New implant offers hope for glaucoma patients failing drops
NCT ID NCT05557058
First seen Nov 20, 2025 · Last updated Jun 13, 2026 · Updated 28 times
Summary
This early study tests a new device called the GORE Glaucoma Drainage Implant in 30 adults with primary open-angle glaucoma that eye drops cannot control or who are at high risk of scarring from standard surgery. The goal is to see if the implant safely lowers eye pressure by at least 20% at 6 months while using the same or fewer eye drops. This is not a cure, but aims to better manage the disease and reduce the need for daily medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Laser Center
Santo Domingo, Dominican Republic
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.